Influence of repetitive transcranial magnetic stimulation on special symptoms in depressed patients

Restorative Neurology and Neuroscience

Volumn 28, Issue 4, 2010, Pages 577-585

  Höppner, Jacqueline ^a   Berger, Christoph ^a   Walter, Uwe ^a   Padberg, Frank ^b   Buchmann, Johannes ^a   Herwig, Uwe ^c   Domes, Gregor ^d  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

BECK DEPRESSION INVENTORY; BRAIN ELECTROPHYSIOLOGY; CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; DOPAMINERGIC TRANSMISSION; HUMAN; NEUROIMAGING; NEUROMODULATION; NONHUMAN; OUTCOME ASSESSMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRANIAL MAGNETIC STIMULATION;

DEPRESSIVE DISORDER; DOPAMINE; HUMANS; MOVEMENT; MULTICENTER STUDIES AS TOPIC; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; SYNAPTIC TRANSMISSION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 77956240745     PISSN: 09226028     EISSN: None     Source Type: Journal    
DOI: 10.3233/RNN-2010-0557     Document Type: Short Survey

References (51)

1. Alex, K.D., Yavanian, G.J., McFarlane, H.G., Pluto, C.P. & Pehek, E.A. (2005). Modulation of dopamine release by striatal 5-HT2C receptors. Synapse, 55, 242-251.
2. Angst, J., Gamma, A., Benazzi, F., Ajdacic, V. & Rossler, W. (2009). Does psychomotor agitation in major depressive episodes indicate bipolarity? Evidence from the Zurich Study. Eur Arch Psychiatry Clin Neurosci, 259, 55-63.
3. Arnsten, A.F. (2009). Stress signalling pathways that impair pre-frontal cortex structure and function. Nat Rev Neurosci, 10, 410-422
4. Becker, G., Berg, D., Lesch, K.P. & Becker, T. (2001). Basal limbic system alteration in major depression: a hypothesis supported by transcranial sonography and MRI findings. Int J Neuropsychopharmacol, 4, 21-31.
5. Becker, G., Seufert, J., Bogdahn, U., Reichmann, H. & Reiners, K. (1995). Degeneration of substantia nigra in chronic Parkinsons disease visualized by transcranial color-coded real-time sonography. Neurology, 45, 182-184.
6. Berg, D., Becker, G., Zeiler, B., Tucha, O., Hofmann, E., Preier, M., Benz, P., Jost, W., Reiners, K. & Lange, K.W. (1999). Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology, 53, 1026-1031.
7. Berg, D., Jabs, B., Merschdorf, U., Beckmann, H. & Becker, G. (2001). Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry, 50, 463-467.
8. Berg, D., Merz, B., Reiners, K., Naumann, M. & Becker, G. (2005). Five-year follow-up study ofhyperechogenicity ofthe substantia nigra in Parkinsons disease. MovDisord, 20, 383-385.
9. Berg, D., Roggendorf, W., Schroder, U., Klein, R., Tatschner, T., Benz, P., Tucha, O., Preier, M., Lange, K.W., Reiners, K., Gerlach, M. & Becker, G. (2002). Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol, 59, 999-1005.
10. Brooks, D.J. & Doder, M. (2001). Depression in Parkinsons disease. Curr Opin Neurol, 14, 465-470.
11. Brus, R., Nowak, P., Szkilnik, R., Mikolajun, U. & Kostrzewa, R.M. (2004). Serotoninergics attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity. NeurotoxRes, 6, 317-325.
12. Burt, T., Lisanby, S.H. & Sackeim, H.A. (2002). Neuropsychiatric applications oftranscranial magnetic stimulation. a meta analysis. International J Neuropsychopharmacol, 5(1), 73-103.
13. Cho, S.S. & Strafella, A.P. (2009). rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PLoS One, 4, e6725.
14. del Olmo, M.F., Bello, O. & Cudeiro, J. (2007). Transcranial magnetic stimulation over dorsolateral prefrontal cortex in Parkinsons disease. Clin Neurophysiol, 118, 131-139.
15. Domes, G., Schulze, L., Bottger, M., Grossmann, A., Hauenstein, K. & Wirtz, P.H. (2010). The neural correlates of sex differences in emotional reactivity and emotion regulation. Hum Brain Mapp, in press.
16. Drag, L.L., Bieliauskas, L.A., Kaszniak, A.W., Bohnen, N.I. & Glisky, E.L. (2009). Source memory and frontal functioning in Parkinsons disease. J Int Neuropsychol Soc, 15, 399-406.
17. Elahi, B., Elahi, B. & Chen, R. (2009). Effect of transcranial magnetic stimulation on Parkinson motor function - systematic review of controlled clinical trials. Mov Disord, 24, 357-363.
18. Epstein, C.M., Evatt, M.L., Funk, A., Girard-Siqueira, L., Lupei, N., Slaughter, L., Athar, S., Green, J., McDonald, W. & DeLong, M.R. (2007). An open study of repetitive transcranial magnetic stimulation in treatment-resistant depression with Parkinsons disease. Clin Neurophysiol, 118,2189-2194.
19. Gershon, A.A., Dannon, P.N. & Grunhaus, L. (2003). Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry, 160, 835-845.
20. Helmich, R.C., Siebner, H.R., Bakker, M., Munchau, A. & Bloem, B.R. (2006). Repetitive transcranial magnetic stimulation to improve mood and motor function in Parkinsons disease. J Neurol Sci, 248, 84-96.
21. Herwig, U., Fallgatter, A.J., Hoppner, J., Eschweiler, G.W., Kron, M., Hajak, G., Padberg, F.,Naderi-Heiden, A., Abler, B., Eichhammer, P., Grossheinrich, N., Hay, B., Kammer, T., Langguth, B., Laske, C., Plewnia, C., Richter, M.M., Schulz, M., Unterecker, S., Zinke, A., Spitzer, M. & Schonfeldt-Lecuona, C. (2007). Antidepressant effects of augmentative transcranial magnetic stimulation. British Journal of Psychiatry, 191, 441-448.
22. Hoeppner, J., Padberg, F., Domes, G., Zinke, A., Herpertz, S.C., Grossheinrich, N. & Herwig, U. (2009). Influence of repetitive transcranial magnetic stimulation on psychomotor symptoms in major depression. Eur Arch Psychiatry Clin Neurosci, in press.
23. Hoeppner, J., Prudente-Morrissey, L., Herpertz, S.C., Benecke, R. & Walter, U. (2009). Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency. Eur Arch Psychiatry Clin Neurosci, 259, 92-97.
24. Hoeppner, J., Schulz, M., Irmisch, G., Mau, R., Schlafke, D. & Richter, J. (2003). Antidepressant efficacy of two different rTMS procedures. High frequency over left versus low frequency over right prefrontal cortex compared with sham stimulation. Eur Arch Psychiatry Clin Neurosci, 253, 103-109.
25. Johnson, K.A., Kelly, S.P., Bellgrove, M.A., Barry, E., Cox, M., Gill, M. & Robertson, I.H. (2007). Response variability in attention deficit hyperactivity disorder: evidence for neuropsychological heterogeneity. Neuropsychologia, 45, 630-638.
26. Kanno, M., Matsumoto, M., Togashi, H., Yoshioka, M. & Mano, Y. (2003). Effects of acute repetitive transcranial magnetic stimulation on extracellular serotonin concentration in the rat prefrontal cortex. J Pharmacol Sci, 93, 451-457.
27. Keck, M.E., Welt, T., Muller, M.B., Erhardt, A., Ohl, F., Toschi, N., Holsboer, F. & Sillaber, I. (2002). Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology, 43, 101-109.
28. Khedr, E.M., Rothwell, J.C., Shawky, O.A., Ahmed, M.A. & Hamdy, A. (2006). Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinsons disease. Mov Disord, 21, 2201-2205.
29. Koenigs, M. & Grafman, J. (2009). The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res, 201, 239-243.
30. Kozel, F.A. & George, M.S. (2002). Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. J Psych Pract, 8(5), 270-275.
31. Leentjens, A.F., Van den Akker, M., Metsemakers, J.F., Lousberg, R. & Verhey, F.R. (2003). Higher incidence of depression preceding the onset of Parkinsons disease: a register study. Mov Disord, 18, 414-418.
32. Lemke, M.R., Puhl, P., Koethe, N. & Winkler, T. (1999). Psychomotor retardation and anhedonia in depression. Acta Psychiatr Scand, 99, 252-256.
33. Loo, C.K. & Mitchell, P.B. (2005). A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. J Affect Disord, 88, 255-267.
34. Martin, J.L., Barbanoj, M.J., Schlaepfer, T.E., Thompson, E., Perez, V. & Kulisevsky, J. (2003). Repetitive transcranial magnetic stimulation for the treatment ofdepression. Systematic review and meta-analysis. Br J Psychiatry, 182,480-491.
35. Meyer, J.H., McNeely, H.E., Sagrati, S., Boovariwala, A., Martin, K., Verhoeff, N.P., Wilson, A.A. & Houle, S. (2006). Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study. Am J Psychiatry, 163, 1594-1602.
36. Nilsson, F.M., Kessing, L.V. & Bolwig, T.G. (2001). Increased risk of developing Parkinsons disease for patients with major affective disorder: a register study. Acta Psychiatr Scand, 104, 380-386.
37. OReardon, J.P., Solvason, H.B., Janicak, P.G., Sampson, S., Isenberg, K.E., Nahas, Z., McDonald, W.M., Avery, D., Fitzgerald, P.B., Loo, C., Demitrack, M.A., George, M.S. & Sackeim, H.A. (2007). Efficacy and safety oftranscranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry, 62, 1208-1216.
38. Ochsner, K.N., Ray, R.D., Cooper, J.C., Robertson, E.R., Chopra, S., Gabrieli, J.D. & Gross, J.J. (2004). For better or for worse: neural systems supporting the cognitive down-and up-regulation of negative emotion. Neuroimage, 23, 483-499.
39. Pogarell, O., Koch, W., Popperl, G., Tatsch, K., Jakob, F., Zwanzger, P., Mulert, C., Rupprecht, R., Moller, H.J., Hegerl, U. & Padberg, F. (2006). Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study. J Psychiatr Res, 40, 307-314.
40. Rubin, R.T., Poland, R.E., Lesser, I.M., Martin, D.J., Blodgett, A.L. & Winston, R.A. (1987). Neuroendocrine aspects of primary endogenous depression. III. Cortisol secretion in relation to diagnosis and symptom patterns. Psychol Med, 17, 609-619.
41. Schuurman, A.G., van den Akker, M., Ensinck, K.T., Metsemakers, J.F., Knottnerus, J.A., Leentjens, A.F. & Buntinx, F. (2002). Increased risk ofParkinsons disease after depression: a retrospective cohort study. Neurology, 58, 1501-1504.
42. Shiba, M., Bower, J.H., Maraganore, D.M., McDonnell, S.K., Peterson, B.J., Ahlskog, J.E., Schaid, D.J. & Rocca, W.A. (2000). Anxiety disorders and depressive disorders preceding Parkinsons disease: a case-control study. Mov Disord, 15, 669-677.
43. Shimamoto, H., Takasaki, K., Shigemori, M., Imaizumi, T., Ayabe, M. & Shoji, H. (2001). Therapeutic effect and mechanism of repetitive transcranial magnetic stimulation in Parkinsons disease. J Neurol, 248(Suppl 3), III48-52.
44. Silton, R.L., Heller, W., Towers, D.N., Engels, A.S., Spielberg, J.M., Edgar, J.C., Sass, S.M., Stewart, J.L., Sutton, B.P., Banich, M.T. & Miller, G.A. (2009). The time course of activity in dorsolateral prefrontal cortex and anterior cingulate cortex during top-down attentional control. Neuroimage, 50(3), 1292-1302.
45. Sobin, C., Mayer, L. & Endicott, J. (1998). The motor agitation and retardation scale: a scale for the assessment of motor abnormalities in depressed patients. J Neuropsychiatry Clin Neurosci, 10(1), 85-92.
46. Sommer, U., Hummel, T., Cormann, K., Mueller, A., Frasnelli, J., Kropp, J. & Reichmann, H. (2004). Detection of presymptomatic Parkinsons disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord, 19, 1196-1202.
47. Tremblay, L.K., Naranjo, C.A., Graham, S.J., Herrmann, N., Mayberg, H.S., Hevenor, S. & Busto, U.E. (2005). Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry, 62, 1228-1236.
48. Walter, U., Hoeppner, J., Prudente-Morrissey, L., Horowski, S., Herpertz, S.C. & Benecke, R. (2007). Parkinsons disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain, 130, 1799-1807.
49. Walter, U., Klein, C., Hilker, R., Benecke, R., Pramstaller, P.P. & Dressler, D. (2004). Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord, 19, 1445-1449.
50. Walter, U., Niehaus, L., Probst, T., Benecke, R., Meyer, B.U. & Dressler, D. (2003). Brain parenchyma sonography discriminates Parkinsons disease and atypical parkinsonian syndromes. Neurology, 60, 74-77
51. Zwanzger, P., Baghai, T.C., Padberg, F., Ella, R., Minov, C., Mikhaiel, P., Schule, C., Thoma, H. & Rupprecht, R. (2003). The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychoneuroendocrinology, 28, 376-385.